Table of Content

1 Influenza Vaccines Market Introduction and Overview
1.1 Influenza Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Influenza Vaccines Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Influenza Vaccines Revenue and Market Share by Type
3 Global Influenza Vaccines Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Influenza Vaccines Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Influenza Vaccines Market Size (2019-2024)
4.2 Influenza Vaccines Growth Trends Analysis by Regions
4.2.1 Influenza Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Influenza Vaccines Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Influenza Vaccines Market Size (2019-2024)
4.2.4 Europe Influenza Vaccines Market Size (2019-2024)
4.2.5 Asia-Pacific Influenza Vaccines Market Size (2019-2024)
4.2.6 Latin America Influenza Vaccines Market Size (2019-2024)
4.2.7 Middle East & Africa Influenza Vaccines Market Size (2019-2024)
5 North America
5.1 North America Influenza Vaccines Revenue by Countries
5.1.1 North America Influenza Vaccines Revenue by Countries (2019-2024)
5.2 North America Influenza Vaccines Revenue by Types
5.3 North America Influenza Vaccines Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Influenza Vaccines Revenue by Countries
6.1.1 Asia Pacific Influenza Vaccines Revenue by Countries (2019-2024)
6.2 Asia Pacific Influenza Vaccines Revenue by Types
6.3 Asia Pacific Influenza Vaccines Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza Vaccines Revenue by Countries
7.1.1 Europe Influenza Vaccines Revenue by Countries (2019-2024)
7.2 Europe Influenza Vaccines Revenue by Types
7.3 Europe Influenza Vaccines Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Influenza Vaccines Revenue by Countries
8.1.1 Latin America Influenza Vaccines Revenue by Countries (2019-2024)
8.2 Latin America Influenza Vaccines Revenue by Types
8.3 Latin America Influenza Vaccines Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Influenza Vaccines Revenue by Countries
9.1.1 Middle East & Africa Influenza Vaccines Revenue by Countries (2019-2024)
9.2 Middle East & Africa Influenza Vaccines Revenue by Types
9.3 Middle East & Africa Influenza Vaccines Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Influenza Vaccines Market Competition, by Players
10.1 Global Influenza Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Influenza Vaccines Players Market Share in 2023
10.2.2 Top 6 Influenza Vaccines Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Influenza Vaccines Players Head Office, Business Provided
10.4 Influenza Vaccines Mergers & Acquisitions
10.5 Influenza Vaccines New Entrants and Expansion Plans
11 Players Profiles11.1 AstraZeneca
11.1.1 AstraZeneca Company Profile
11.1.2 Influenza Vaccines Product Overview
11.1.3 AstraZeneca Influenza Vaccines Market Performance (2019-2024)
11.1.4 AstraZeneca Business Overview
11.1.5 Recent Developments and Plans
11.2 CSL
11.2.1 CSL Company Profile
11.2.2 Influenza Vaccines Product Overview
11.2.3 CSL Influenza Vaccines Market Performance (2019-2024)
11.2.4 CSL Business Overview
11.2.5 Recent Developments and Plans
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Profile
11.3.2 Influenza Vaccines Product Overview
11.3.3 GlaxoSmithKline Influenza Vaccines Market Performance (2019-2024)
11.3.4 GlaxoSmithKline Business Overview
11.3.5 Recent Developments and Plans
11.4 Sanofi
11.4.1 Sanofi Company Profile
11.4.2 Influenza Vaccines Product Overview
11.4.3 Sanofi Influenza Vaccines Market Performance (2019-2024)
11.4.4 Sanofi Business Overview
11.4.5 Recent Developments and Plans
11.5 Altimmune
11.5.1 Altimmune Company Profile
11.5.2 Influenza Vaccines Product Overview
11.5.3 Altimmune Influenza Vaccines Market Performance (2019-2024)
11.5.4 Altimmune Business Overview
11.5.5 Recent Developments and Plans
11.6 BionVax
11.6.1 BionVax Company Profile
11.6.2 Influenza Vaccines Product Overview
11.6.3 BionVax Influenza Vaccines Market Performance (2019-2024)
11.6.4 BionVax Business Overview
11.6.5 Recent Developments and Plans
11.7 FluGen
11.7.1 FluGen Company Profile
11.7.2 Influenza Vaccines Product Overview
11.7.3 FluGen Influenza Vaccines Market Performance (2019-2024)
11.7.4 FluGen Business Overview
11.7.5 Recent Developments and Plans
11.8 FOLIA BIOTECH
11.8.1 FOLIA BIOTECH Company Profile
11.8.2 Influenza Vaccines Product Overview
11.8.3 FOLIA BIOTECH Influenza Vaccines Market Performance (2019-2024)
11.8.4 FOLIA BIOTECH Business Overview
11.8.5 Recent Developments and Plans
11.9 Genentech
11.9.1 Genentech Company Profile
11.9.2 Influenza Vaccines Product Overview
11.9.3 Genentech Influenza Vaccines Market Performance (2019-2024)
11.9.4 Genentech Business Overview
11.9.5 Recent Developments and Plans
11.10 Green Cross
11.10.1 Green Cross Company Profile
11.10.2 Influenza Vaccines Product Overview
11.10.3 Green Cross Influenza Vaccines Market Performance (2019-2024)
11.10.4 Green Cross Business Overview
11.10.5 Recent Developments and Plans
11.11 Medicago
11.11.1 Medicago Company Profile
11.11.2 Influenza Vaccines Product Overview
11.11.3 Medicago Influenza Vaccines Market Performance (2019-2024)
11.11.4 Medicago Business Overview
11.11.5 Recent Developments and Plans
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Profile
11.12.2 Influenza Vaccines Product Overview
11.12.3 Moderna Therapeutics Influenza Vaccines Market Performance (2019-2024)
11.12.4 Moderna Therapeutics Business Overview
11.12.5 Recent Developments and Plans
11.13 Novavax
11.13.1 Novavax Company Profile
11.13.2 Influenza Vaccines Product Overview
11.13.3 Novavax Influenza Vaccines Market Performance (2019-2024)
11.13.4 Novavax Business Overview
11.13.5 Recent Developments and Plans
12 Global Influenza Vaccines Forecast Market Analysis by Type
12.1 Global Influenza Vaccines Revenue Market Forecast by Type (2024-2030)
13 Global Influenza Vaccines Forecast Market Analysis by Application
13.1 Influenza Vaccines Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Influenza Vaccines Forecast Market Size (2024-2030)
14.2 Influenza Vaccines Growth Trends Forecast Analysis by Regions
14.2.1 Influenza Vaccines Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Influenza Vaccines Forecast Market Size (2024-2030)
14.2.3 Europe Influenza Vaccines Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Influenza Vaccines Forecast Market Size (2024-2030)
14.2.5 Latin America Influenza Vaccines Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Influenza Vaccines Forecast Market Size (2024-2030)
15 Influenza Vaccines Industry Dynamic Analysis
15.1 Influenza Vaccines Market Trends Analysis
15.2 Influenza Vaccines Market Drivers Analysis
15.3 Influenza Vaccines Market Challenges Analysis
15.4 Influenza Vaccines Market Restraints Analysis